Dietary lipids in the aetiology of Alzheimer's disease: implications for therapy

作者: Janelle L Cooper

DOI: 10.2165/00002512-200320060-00001

关键词:

摘要: Amyloid plaques and neurofibrillary tangles are the neuropathological hallmarks of Alzheimer's disease (AD), but no conclusive evidence has emerged showing that these cause not a product disease. Many studies have implicated oxidation inflammation in AD process, there is growing abnormalities lipid metabolism also play role. Using epidemiology to elucidate risk factors histological changes suggest possible mechanisms, hypothesis advanced dietary lipids principal factor for development late-onset sporadic AD. The degree saturation fatty acids position first double bond essential most critical determining effect fats on AD, with unsaturated n-3 bonds conferring protection an overabundance saturated or n-6 increasing risk. interaction apolipoprotein E isoforms may determine rate sustained autoperoxidation within cellular membranes efficacy membrane repair. Interventions involving show great promise slowing possibly averting including changes, cholesterol-modifying agents antioxidants.

参考文章(262)
Rosemary C Wander, Shi-Hua Du, Oxidation of plasma proteins is not increased after supplementation with eicosapentaenoic and docosahexaenoic acids The American Journal of Clinical Nutrition. ,vol. 72, pp. 731- 737 ,(2000) , 10.1093/AJCN/72.3.731
KATSUHIKO YANAGISAWA, ASANO ASAMI-ODAKA, NOBUHIRO SUZUKI, YASUO IHARA, Fractionation of Amyloid β‐Protein (Aβ) in Alzheimer's Disease and Down's Syndrome Brains Annals of the New York Academy of Sciences. ,vol. 786, pp. 184- 194 ,(1996) , 10.1111/J.1749-6632.1996.TB39061.X
Domenico Praticò, Kunihiro Uryu, Susan Leight, John Q. Trojanoswki, Virginia M.-Y. Lee, Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis. The Journal of Neuroscience. ,vol. 21, pp. 4183- 4187 ,(2001) , 10.1523/JNEUROSCI.21-12-04183.2001
Charles-André Cuénod, David B Kaplan, Jean-Luc Michot, Philippe Jehenson, Anne Leroy-Willig, Françoise Forette, André Syrota, François Boiler, Phospholipid Abnormalities in Early Alzheimer's Disease: In Vivo Phosphorus 31 Magnetic Resonance Spectroscopy JAMA Neurology. ,vol. 52, pp. 89- 94 ,(1995) , 10.1001/ARCHNEUR.1995.00540250097018
Sandra Locatelli, Dieter Lütjohann, Hartmut H.-J. Schmidt, Carsten Otto, Ulrike Beisiegel, Klaus von Bergmann, Reduction of Plasma 24S-Hydroxycholesterol (Cerebrosterol) Levels Using High-Dosage Simvastatin in Patients With Hypercholesterolemia Archives of Neurology. ,vol. 59, pp. 213- 216 ,(2002) , 10.1001/ARCHNEUR.59.2.213
Shiro Kashiwagi, Kazuyuki Nakamura, Hirofumi Arai, Hiroshi Yamashita, Haruhide Ito, Electrophoretic analysis of oxidative modification of apolipoprotein E in very low density lipoprotein from fresh human plasma. Electrophoresis. ,vol. 20, pp. 1418- 1424 ,(1999) , 10.1002/(SICI)1522-2683(19990601)20:7<1418::AID-ELPS1418>3.0.CO;2-B
Suzanne M de la Monte, Tri Luong, Thomas R Neely, Diedra Robinson, Jack R Wands, Mitochondrial DNA damage as a mechanism of cell loss in Alzheimer's disease. Laboratory Investigation. ,vol. 80, pp. 1323- 1335 ,(2000) , 10.1038/LABINVEST.3780140
JUDES POIRIER, Apolipoprotein E and Alzheimer's Disease A Role in Amyloid Catabolism Annals of the New York Academy of Sciences. ,vol. 924, pp. 81- 90 ,(2006) , 10.1111/J.1749-6632.2000.TB05564.X